Default company panoramic image

Sapientia Pharmaceuticals

The Mission of SPI is to develop novel pharmaceuticals for the treatment of Systemic Sclerosis and other fibrotic disorders.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Rye, NY, USA
  • Currency USD
  • Website

Company Summary


  • Default avatar
    William V Williams, MD
    Chief Executive Officer

  • Default avatar
    James B Hoffman
    Chief Operating Officer